219 related articles for article (PubMed ID: 16104005)
1. Combined chemotherapy and teratogenicity.
Paskulin GA; Gazzola Zen PR; de Camargo Pinto LL; Rosa R; Graziadio C
Birth Defects Res A Clin Mol Teratol; 2005 Sep; 73(9):634-7. PubMed ID: 16104005
[TBL] [Abstract][Full Text] [Related]
2. Apparent cyclophosphamide (cytoxan) embryopathy: a distinct phenotype?
Enns GM; Roeder E; Chan RT; Ali-Khan Catts Z; Cox VA; Golabi M
Am J Med Genet; 1999 Sep; 86(3):237-41. PubMed ID: 10482872
[TBL] [Abstract][Full Text] [Related]
3. Teratogen update: methotrexate.
Hyoun SC; Običan SG; Scialli AR
Birth Defects Res A Clin Mol Teratol; 2012 Apr; 94(4):187-207. PubMed ID: 22434686
[TBL] [Abstract][Full Text] [Related]
4. Neonatal effects of breast cancer chemotherapy administered during pregnancy.
Kerr JR
Pharmacotherapy; 2005 Mar; 25(3):438-41. PubMed ID: 15843292
[TBL] [Abstract][Full Text] [Related]
5. Treatment of breast cancer during pregnancy: an observational study.
Loibl S; Han SN; von Minckwitz G; Bontenbal M; Ring A; Giermek J; Fehm T; Van Calsteren K; Linn SC; Schlehe B; Gziri MM; Westenend PJ; Müller V; Heyns L; Rack B; Van Calster B; Harbeck N; Lenhard M; Halaska MJ; Kaufmann M; Nekljudova V; Amant F
Lancet Oncol; 2012 Sep; 13(9):887-96. PubMed ID: 22902483
[TBL] [Abstract][Full Text] [Related]
6. The effect of chemotherapy in pregnant women on the teeth of offspring.
Peretz B; Peretz T
Pediatr Dent; 2003; 25(6):601-4. PubMed ID: 14733479
[TBL] [Abstract][Full Text] [Related]
7. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero.
Hahn KM; Johnson PH; Gordon N; Kuerer H; Middleton L; Ramirez M; Yang W; Perkins G; Hortobagyi GN; Theriault RL
Cancer; 2006 Sep; 107(6):1219-26. PubMed ID: 16894524
[TBL] [Abstract][Full Text] [Related]
8. Teratogenicity and carcinogenicity in a twin exposed in utero to cyclophosphamide.
Zemlickis D; Lishner M; Erlich R; Koren G
Teratog Carcinog Mutagen; 1993; 13(3):139-43. PubMed ID: 8105555
[TBL] [Abstract][Full Text] [Related]
9. Specific congenital malformations after exposure to cyclophosphamide, epirubicin and 5-fluorouracil during the first trimester of pregnancy.
Leyder M; Laubach M; Breugelmans M; Keymolen K; De Greve J; Foulon W
Gynecol Obstet Invest; 2011; 71(2):141-4. PubMed ID: 21160143
[TBL] [Abstract][Full Text] [Related]
10. Adult and two children with fetal methotrexate syndrome.
Bawle EV; Conard JV; Weiss L
Teratology; 1998 Feb; 57(2):51-5. PubMed ID: 9562676
[TBL] [Abstract][Full Text] [Related]
11. Cancer chemotherapeutic agents as human teratogens.
Selig BP; Furr JR; Huey RW; Moran C; Alluri VN; Medders GR; Mumm CD; Hallford HG; Mulvihill JJ
Birth Defects Res A Clin Mol Teratol; 2012 Aug; 94(8):626-50. PubMed ID: 22851372
[TBL] [Abstract][Full Text] [Related]
12. Fetal outcome after in utero exposure to cancer chemotherapy.
Zemlickis D; Lishner M; Degendorfer P; Panzarella T; Sutcliffe SB; Koren G
Arch Intern Med; 1992 Mar; 152(3):573-6. PubMed ID: 1546920
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy with taxanes in breast cancer during pregnancy: case report and review of the literature.
Potluri V; Lewis D; Burton GV
Clin Breast Cancer; 2006 Jun; 7(2):167-70. PubMed ID: 16800979
[TBL] [Abstract][Full Text] [Related]
14. Perinatal outcomes of a pregnancy complicated by cancer, including neonatal follow-up after in utero exposure to chemotherapy: results of an international registry.
Cardonick E; Usmani A; Ghaffar S
Am J Clin Oncol; 2010 Jun; 33(3):221-8. PubMed ID: 19745695
[TBL] [Abstract][Full Text] [Related]
15. Use of chemotherapy during human pregnancy.
Cardonick E; Iacobucci A
Lancet Oncol; 2004 May; 5(5):283-91. PubMed ID: 15120665
[TBL] [Abstract][Full Text] [Related]
16. Development of children born to mothers with cancer during pregnancy: comparing in utero chemotherapy-exposed children with nonexposed controls.
Cardonick EH; Gringlas MB; Hunter K; Greenspan J
Am J Obstet Gynecol; 2015 May; 212(5):658.e1-8. PubMed ID: 25434835
[TBL] [Abstract][Full Text] [Related]
17. Children exposed to chemotherapy in utero.
Gwyn K
J Natl Cancer Inst Monogr; 2005; (34):69-71. PubMed ID: 15784828
[TBL] [Abstract][Full Text] [Related]
18. Prenatal detection of multiple fetal anomalies following inadvertent exposure to cyclophosphamide in the first trimester of pregnancy.
Paladini D; Vassallo M; D'Armiento MR; Cianciaruso B; Martinelli P
Birth Defects Res A Clin Mol Teratol; 2004 Feb; 70(2):99-100. PubMed ID: 14991918
[No Abstract] [Full Text] [Related]
19. Reviewing the evidence for mycophenolate mofetil as a new teratogen: case report and review of the literature.
Anderka MT; Lin AE; Abuelo DN; Mitchell AA; Rasmussen SA
Am J Med Genet A; 2009 Jun; 149A(6):1241-8. PubMed ID: 19441125
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of children exposed in utero to chemotherapy for breast cancer.
Murthy RK; Theriault RL; Barnett CM; Hodge S; Ramirez MM; Milbourne A; Rimes SA; Hortobagyi GN; Valero V; Litton JK
Breast Cancer Res; 2014 Dec; 16(6):500. PubMed ID: 25547133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
